Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort.
Kate E FoleyZachary WinderTiffany L SudduthBarbara J MartinPeter T NelsonGregory A JichaJordan P HarpErica M WeekmanDonna M WilcockPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Large community cohorts studying sex, age, and APOE genotype effects on biomarkers are few. It is unknown how biomarker-biomarker associations vary through aging and dementia. Six AD (Aβ40, Aβ42, Aβ42/40, p-tau181, total tau, and NfLight) and five inflammatory biomarkers (TNFα, IL6, IL8, IL10, and GFAP) were used to examine associations between biomarkers. Plasma biomarkers suggesting increasing cerebral AD pathology corresponded to increases in peripheral inflammatory markers, both pro-inflammatory and anti-inflammatory. Strength of correlations, between pairs of classic AD and inflammatory plasma biomarker, changes throughout cognitive progression to dementia.